← Back to Search

Personalized eToolkit for Tobacco Use (SWYW2 Trial)

N/A
Waitlist Available
Led By Payal Agarwal, MD
Research Sponsored by Women's College Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months post appointment
Awards & highlights

SWYW2 Trial Summary

Screening While You Wait 2: Alcohol and Tobacco Use

Eligible Conditions
  • Tobacco Use
  • Alcohol Use Disorder
  • Quitting Smoking
  • Alcohol Abuse

SWYW2 Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months post appointment
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months post appointment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Discussion around risky substance use in clinic visit
Updated Cumulative Patient Profile (CPP) Status
Secondary outcome measures
Level of satisfaction with intervention
PCP administration of treatment resources/programs
PCP provisioning of pharmacotherapy
+5 more

SWYW2 Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Personalized eToolkitExperimental Treatment1 Intervention
The intervention arm will receive a personalized eToolkit with community and electronic supports upon survey completion, and their PCP will receive automatic supports in the EMR to assess and treat the patient's alcohol and/or tobacco use. In cases where a patient does not have risky alcohol and tobacco use, a personalized eToolkit based on their physical activity levels will be administered, and their PCP will receive automatic supports in the EMR to facilitate physical activity discussions. Intervention arm patient participants will be asked to complete a baseline e-survey before their scheduled appointment, a process evaluation e-survey 3 days following their appointment, and a 3 months follow-up e-survey following their appointment. Resources will be automatically produced for the patient and PCP following completion of the baseline e-survey.
Group II: Usual careActive Control1 Intervention
The control arm will not receive intervention materials. Control arm patient participants will be asked to complete a baseline e-survey before their scheduled appointment, a process evaluation e-survey 3 days following their appointment, and 3 months follow-up e-survey following their appointment.

Find a Location

Who is running the clinical trial?

Women's College HospitalLead Sponsor
101 Previous Clinical Trials
38,732 Total Patients Enrolled
Payal Agarwal, MDPrincipal InvestigatorWomen's College Hospital

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Screening While You Wait 2: Alcohol and Tobacco Use
Payal Agarwal 2020. "Screening While You Wait 2: Alcohol and Tobacco Use". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04594304.
~69 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top